Your Search
- All results
- Pages
- Articles in the press
- Brochures
- Company news
- Educational resources
- News
- Podcasts
- Press releases
- Videos
- Events
Outsourcing Formulation Development and Manufacturing: CDMOs Shift to Offer More Specialized Services
Meeting modern consumer expectations through specialist formulation expertiseIncreasing demand for personalized medicines and supplements is broadening the market for dosage forms that are quick, convenient and safe for people to use. As a result, many product developers are turning to contract development and manufacturing organizations (CDMOs) …
Don’t Forget About the Patient
Pharma manufacturers are not embracing patient-centric design when it comes to formulation. We need to go beyond tablets and capsules.Designing products that cater to the needs of those who use them seems logical for any competitive market. Yet tablets and capsules, which cause problems for …
Creating User-Friendly Oral Dosage Forms
The use of electronic tongue technology helps firms reduce development times and costs by overcoming challenges associated with traditional testing panels.Ensuring medicines taste pleasant is necessary to achieve high levels of patient compliance, and this is especially important for user-friendly formulations which are tasted more …
A User-Friendly Approach to Developing an Extended-Release Product
The challenge of achieving sustained delivery of an active ingredient or nutrient can be achieved with extended-release formulations.To treat many conditions effectively, it can be beneficial for the active pharmaceutical ingredient or nutrient to be delivered to the body over a prolonged period of time. …
HERMES PHARMA joins the Consumer Healthcare Products Association (CHPA)
HERMES PHARMA is committed to making medicines more user-friendly in the USMunich/Grosshesselohe, Germany – October 6, 2011 – HERMES PHARMA, the expert in developing and manufacturing user-friendly solid oral dosage forms, today announced that it has joined the Consumer Healthcare Products Association (CHPA). CHPA is the …
Ensuring Patient Adherence in Paediatric and Geriatric Populations
Patient noncompliance costs US healthcare payers an estimated $330 billion annually, according to a recent study. With value of care increasingly determining a medicine’s market success, many pharmaceutical companies are recognizing the importance of adopting a patient-centric approach to formulation development, especially for products designed …
In the Best Possible Taste – Accelerating Formulation Development and Delivering More Reliable Results using electronic tongues
Given the inherently bitter taste of many active pharmaceutical ingredients, a key challenge for developers is how best to use flavorings and taste-masking technologies to make oral dosage forms taste more pleasant. With traditional methods of assessing taste suffering from a number of important limitations …
QbD: Improving Pharmaceutical Development and Manufacturing Workflows to Deliver Better Patient Outcomes
There is growing appreciation within the pharmaceutical industry that late-stage QC testing may not be the most effective or efficient way to deliver quality products. After all, quality cannot be ‘tested’ into a product – it should be there by design. As a result, many …
Hot Melt Coating for Creating User-friendly Extended Release Formulations
Time and again, pharmaceutical companies are faced with the need to develop a single dosage form that produces a constant blood plasma concentration at an effective level over a prolonged period of time. Often, the solution will be an extended release formulation that delivers the …
How Advances in Pharmaceutical Packaging Are Better Meeting Patients’ Needs
When developing oral dosage forms that are convenient to take and meet individuals’ needs, it’s not just the formulations themselves that must be user-friendly. Product packaging must also enable the product to be easily incorporated into patients and consumers’ daily lives.In this article featured in …